• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Charts of the Week: Boston Scientific, Alkermes, Snap-on, Stanley Black & Decker

These four names stood out to me from a weekly perspective.
By TIMOTHY COLLINS
Nov 08, 2015 | 08:00 PM EST
Stocks quotes in this article: BSX, ALKS, SNA, SWK

While the overall market demonstrated a little exhaustion late in the week, there are several names setting up well from a weekly view.

Four names stood out to me with basically a breakdown of two groups of two.

The first two comes from the medical device sector.

After a strong two weeks, Boston Scientific (BSX) has pushed over price resistance from the spring. The weekly chart is seeing multiple bullish crossovers along with this current price breakout. The MACD and Vortex Indicator (VTX) are both pushing bullish while the Relative Strength Index (RSI) just hit 70. The last big run from BSX came when these bullish crossovers occurred and the run continued a long time while the RSI was above 70. The bullish move did not end until we saw the RSI drop back below 70 and the MACD crossed bearish. I don't believe this current breakout has the same potential as the breakout from November 2014, but a minimal target of $21 here with the potential for $23 sits in the weekly chart. A close back under $18 put this one into neutral territory, while a close under $16.75 will cause many bulls to abandon ship.

Boston Scientific (BSX)
Source: StockCharts.com
View Chart » View in New Window »

Although not as strong, Alkermes (ALKS) is a chart waiting to break out. Bears have had their chances with this one, but notice all the bearish rejections in the yellow highlighted box. The stock has found rock-steady buyers every trip below $60 and down to $55. What makes this chart a bit more difficult is we don't have a breakout on price yet, nor do we have clean bullish crossovers on the MACD or VTX. The trend isn't clearly bullish yet. The RSI is still strong, but I would prefer to see a new high here.

Alkermes (ALKS)
Source: StockCharts.com
View Chart » View in New Window »

ALKS does have strength in the volume here as the On Balance Volume is pushing well above the 21-week simple moving average. The target on a breakout here is $80-82, but we really needs to see a close above last week's highs. This one is worth a watch, but isn't quite into buying territory yet.

If you don't like healthcare, there are a few names in the industrial goods sector. Snap-on (SNA) broke out last week. After a nine-month run, SNA consolidated in a rounding pattern and now looks to break higher. Price is above resistance and has its targets set on $185 here. RSI is very strong with the stock performing well as long as it has stayed above 50, but best over 65. The VTX is muddled, but we do have a bullish crossover on the MACD. A continuation of the MACD along with the On Balance Volume crossing above the 21-week simple moving average here should give bulls a bit more confidence going forward.

Snap-on (SNA)
Source: StockCharts.com
View Chart » View in New Window »

Similar to the healthcare setup, Stanley Black & Decker (SWK) looks set up to break out, but has not triggered yet. The plus here is secondary indicators are strong or poised to break out along with price. RSI is trending higher while both the VTX and MACD has crossed over bullish. Another small push higher in price this week and we should see the On Balance Volume push above the 21-week SMA, which should be enough to trigger bullish buyers. I would target an upside of $120. But just like ALKS, I would be patient and wait for the breakout.

Stanley Black & Decker (SWK)
Source: StockCharts.com
View Chart » View in New Window »

The choice between these comes down to whether a trader prefers a stock with a potential for price breakout or a stock one week into a price breakout. I prefer a combination of something like BSX plus SWK once it breaks out above last week's high, but this one comes down to preference as all the setups have something to offer.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Collins had no positions in any of the securities mentioned.

TAGS: Investing | U.S. Equity | Stocks

More from Investing

Corrective Action Produces Fading Confidence and Technical Damage

James "Rev Shark" DePorre
Feb 26, 2021 5:08 PM EST

It's dangerous to have too much exposure now, but the potential for a good recovery is there once interest rate issues are digested.

I'm Intrigued by the Recent Pullback in Aurora Mobile

Timothy Collins
Feb 26, 2021 3:30 PM EST

While the Chinese company is still not profitable, it is cash flow positive.

Salesforce Gets a Quant Downgrade on Top of Weakening Charts

Bruce Kamich
Feb 26, 2021 12:50 PM EST

Here's what investors and traders need to think about.

My Preference Right Now Is to Buy Pre-Deals

Timothy Collins
Feb 26, 2021 12:36 PM EST

I've added a few names that I see as a great risk-reward because of the limited downside.

I've Been a Buyer Friday, Making Partial Buys Like I Always Do

James "Rev Shark" DePorre
Feb 26, 2021 12:07 PM EST

It's premature to predict that a low has been made, but plenty of stocks are quite washed-out already and are starting to find support.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:32 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Navigating a Market Correction
  • 11:29 AM EST GARY BERMAN

    Where Does the Nasdaq Go From Here?

    Where does the Nasdaq Composite (CCMP) index go fr...
  • 12:31 PM EST GARY BERMAN

    Has the Short-Term Top Come for the XLF/Banks?

    The has triggered a long-term overbought signal ...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login